Comparison of skeletal muscle mass loss in patients with metastatic colorectal cancer treated with regorafenib or TAS-102

MLA

Muhammet, Bekir Hacioglu, et al. “Comparison of Skeletal Muscle Mass Loss in Patients with Metastatic Colorectal Cancer Treated with Regorafenib or TAS-102.” Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology, vol. 24, no. 5, Dec. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........1e9f6b9919fdad63fc8f87717740d380&authtype=sso&custid=ns315887.

APA

Muhammet, B. H., Osman, K., Nazmi, K., Ahmet, K., Ali, G., Fethi Emre, U., Fatih, K., Nermin, T., Sernaz, U., Ahmet, B., Irfan, C., & Bulent, E. (2019). Comparison of skeletal muscle mass loss in patients with metastatic colorectal cancer treated with regorafenib or TAS-102. Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology, 24(5).

Chicago

Muhammet, Bekir Hacioglu, Kostek Osman, Kurt Nazmi, Kucukarda Ahmet, Gokyer Ali, Ustabasioglu Fethi Emre, Karatas Fatih, et al. 2019. “Comparison of Skeletal Muscle Mass Loss in Patients with Metastatic Colorectal Cancer Treated with Regorafenib or TAS-102.” Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology 24 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........1e9f6b9919fdad63fc8f87717740d380&authtype=sso&custid=ns315887.